ORIGINAL RESEARCH article
Front. Trop. Dis.
Sec. Disease Prevention and Control Policy
Volume 6 - 2025 | doi: 10.3389/fitd.2025.1656222
This article is part of the Research TopicFrom Biological Collections to Solutions: The Vital Role of Biobanking in One Health and Global HealthView all 4 articles
Bridging Borders: The Virtual Biorepository System, A Sustainable Global Biobanking System for Epidemic Threats Preparedness
Provisionally accepted- 1Colorado School of Public Health Center for Global Health, Aurora, United States
- 2Dartmouth Hitchcock Clinics department of Community and Family Medicine, Hanover, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Frequent outbreaks of diseases such as Ebola, dengue fever, Zika, and COVID-19 have highlighted the urgent need for equitable timely access to high-quality biological specimens and associated data for diagnostics, vaccine development, and research. However, infectious disease collections and biorepositories frequently have narrow mandates, prioritize internal goals, and lack global coordination. The Virtual Biorepository System (VBS) aims to transform this landscape by connecting local biorepositories, especially in low- and middle-income countries (LMICs), into a federated, trust-based network that promotes global equity, access, and resilience during public health emergencies. Methods: Under the CONTAGIO program, a pilot known as "10x10" was launched to test the feasibility of the VBS model. Ten founding member institutions from LMICs were selected based on location, specimens sharing and biorepository experience, interest, and willingness to engage for at least three years. Each site agreed to collect and share ten mL of plasma or serum from ten individuals, allowing assessment of molecular/immunological testing capacity and shipping logistics, and development of governance and a sustainable business model. Coordination was managed virtually through regular meetings and workshops, with the Center for Global Health (CGH) being the managing partner and as co-technical lead along with University Aix-Marselles. Results: Participating sites included national reference labs, accredited biorepositories, academic institutions, and newer biorepositories. Motivations for participation included networking opportunities, capacity building, contributing to epidemic preparedness, and increasing knowledge of regulatory and logistical challenges related to specimen sharing. Benefits included enhanced collaboration, technical capacity development, and alignment with global outbreak response efforts. Discussion: The 10x10 pilot demonstrates the implementation of the VBS model and identifies known and emerging barriers to specimen access. Its LMIC-focused design enhances the representativeness of samples for diagnostic and vaccine development, addressing long-standing equity gaps. Lessons from the pilot will inform scale-up and refinement of governance, data harmonization, and sustainability strategies. Conclusions: The VBS, through the 10x10 pilot, has shown strong early feasibility and collaboration, reinforcing the demand for an equitable biorepository system for preparedness. Continued development under the CONTAGIO program will build global biobanking capacity and improve epidemic preparedness.
Keywords: Biorepository1, Specimen sharing2, Epidemic preparedness3, Pilot Study4, LMIC5
Received: 29 Jun 2025; Accepted: 29 Sep 2025.
Copyright: © 2025 Giri, Price, Steinberg, Jaenisch and Chu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Judith Giri, judith.giri@cuanschutz.edu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.